As per the new sub-rule named as (5A), the manufacturers of drug formulations specified in the Schedule H2 of the Rule should print or affix barcode or QR code on its primary packaging label. In case ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback